Amneal Pharmaceuticals, Inc. (AMRX)
17.78
-0.13
(-0.73%)
USD |
NASDAQ |
Aug 24, 16:00
17.77
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Net Income (Quarterly) : 69.61M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.61M |
| March 31, 2026 | 78.00M |
| December 31, 2025 | 49.57M |
| September 30, 2025 | 18.13M |
| June 30, 2025 | 35.61M |
| March 31, 2025 | 24.62M |
| December 31, 2024 | -20.74M |
| September 30, 2024 | 11.76M |
| June 30, 2024 | 16.79M |
| March 31, 2024 | -81.68M |
| December 31, 2023 | -93.34M |
| September 30, 2023 | 25.03M |
| June 30, 2023 | 29.68M |
| March 31, 2023 | -10.09M |
| December 31, 2022 | -5.858M |
| September 30, 2022 | -2.39M |
| June 30, 2022 | -240.08M |
| March 31, 2022 | -6.46M |
| December 31, 2021 | -20.46M |
| September 30, 2021 | -6.092M |
| June 30, 2021 | 32.18M |
| March 31, 2021 | 14.54M |
| December 31, 2020 | -6.962M |
| September 30, 2020 | -22.03M |
| June 30, 2020 | -23.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 121.52M |
| December 31, 2019 | -64.90M |
| September 30, 2019 | -363.39M |
| June 30, 2019 | -50.53M |
| March 31, 2019 | -124.75M |
| December 31, 2018 | -20.33M |
| September 30, 2018 | 17.46M |
| June 30, 2018 | -49.75M |
| March 31, 2018 | 0.117M |
| December 31, 2017 | 0.625M |
| September 30, 2017 | 0.342M |
| June 30, 2017 | 0.302M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -279.58M |
| September 30, 2016 | -179.34M |
| June 30, 2016 | -2.701M |
| March 31, 2016 | -10.41M |
| December 31, 2015 | 11.43M |
| September 30, 2015 | 35.76M |
| June 30, 2015 | -1.852M |
| March 31, 2015 | -6.333M |
| December 31, 2014 | 0.12M |
| September 30, 2014 | 15.74M |
| June 30, 2014 | 35.07M |
| March 31, 2014 | 6.425M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Liquidia Corp. | 74.72M |
| Eli Lilly & Co. | 7.095B |
| Indivior Pharmaceuticals, Inc. | 122.00M |
| Viatris, Inc. | -118.80M |
| Pfizer Inc. | -246.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 796.20M |
| Total Expenses (Quarterly) | 738.54M |
| EPS Diluted (Quarterly) | 0.1757 |
| Enterprise Value | 8.459B |
| Gross Profit Margin (Quarterly) | 42.01% |
| Profit Margin (Quarterly) | 8.74% |
| Earnings Yield | 2.70% |
| Operating Earnings Yield | 8.19% |
| Normalized Earnings Yield | 3.494 |